No study has compared injecting near an injury against injecting elsewhere for these compounds "inject near the injury" is a reasonable, low-cost default, but it is practitioner convention, not an evidence-backed advantage
One study utilized chitosan nanoparticles, a biocompatible and biodegradable polymer, as a carrier for doxorubicin and AOD 9604
It has been tested in six clinical trials involving around 900 test subjects and has been determined by an appropriately qualified GRAS panel of experts to be Generally Recognized As Safe (GRAS) under conditions of intended uses of AOD9604 in foods [1]
How do you cure vitamin B12 deficiency
It does this by: Activating beta-3 adrenergic receptors stimulates fat breakdown and mobilization Enhancing lipolysis promotes the use of stored fat as energy Inhibiting lipogenesis reduces the formation of new fat cells In early studies, researchers observed that AOD9604 may help increase fat oxidation and improve metabolic flexibility, especially in overweight or obese individuals